Ascendiant Capital Starts Repros Therapeutics (RPRX) at Strong Buy; Advancing Two Products Into Phase 3 Makes Shares Attractive

Go back to Ascendiant Capital Starts Repros Therapeutics (RPRX) at Strong Buy; Advancing Two Products Into Phase 3 Makes Shares Attractive
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 60.90 -0.83 (1.34%)
Previous Close $61.73    52 Week High $3.48 
Open $61.33    52 Week Low $0.80 
Day High $62.13    P/E N/A 
Day Low $60.80    EPS $-1.54 
Volume 1,500,598